CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
1156-1170 of 1225
Closing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
CME/CEClosing the Gap to Care: Assessing CAD and Improving Patient Outcomes with Revascularization
Adam DeVore, MD
Lauren Barron, MD
Navin Kapur, MD
Case Management Strategies for Patients with ADPKD – Part 1
CME/CECase Management Strategies for Patients with ADPKD – Part 1
Fouad T. Chebib, MD
Pranav S. Garimella, MD
Treatment Options for Invasive Fungal Infections: Why They Don't Always Work
CME/CETreatment Options for Invasive Fungal Infections: Why They Don't Always Work
Thomas F. Patterson, MD, FACP, FIDSA
George Thompson III, MD, FIDSA
Invasive Fungal Infections: More Common Than You Think
CME/CEInvasive Fungal Infections: More Common Than You Think
Peter G. Pappas, MD, FACP
Thomas F. Patterson, MD, FACP, FIDSA
Alloimmune Neutropenia of the Fetus and Newborn
CME/CEAlloimmune Neutropenia of the Fetus and Newborn
Lee P. Shulman, MD, FACMG, FACOG
Masja de Haas, MD, PhD
Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
CME/CEExpert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC
Mark Socinski, MD
Patrick Forde, M.B.B.Ch.
Karen Reckamp, MS, MD
- advertisement
Current and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
CME/CECurrent and Emerging Roles of Immunotherapy and ADCs for Patients with Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
Mamta Parikh, MD, MS
Daniel P. Petrylak, MD
Current Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
CME/CECurrent Standards and Future Opportunities for ADCs in Advanced/Metastatic Triple-Negative Breast Cancer
William J. Gradishar, MD
Javier Cortes, MD, PhD
Hope S. Rugo, MD, FASCO
Kristen Nowak, PhD
Utilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
CME/CEUtilization and Management of Antibody-Drug Conjugates in Metastatic Breast Cancer: The Relationship Between ADCs and HER2
William J. Gradishar, MD
Javier Cortes, MD, PhD
Hope S. Rugo, MD, FASCO
Virtual IBD Clinic: Surgical and Pharmacological Therapeutics
CME/CEVirtual IBD Clinic: Surgical and Pharmacological Therapeutics
Jenny S. Sauk, MD
- advertisement
Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies
CME/CEVirtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies
Sushila R. Dalal, MD
Meyeon Park, MD, MAS
Anjay Rastogi, MD, PhD
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
CME/CEEmploying Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
Robert L. Coleman, MD, FACOG, FACS
Susana Campos, MD, MPH
Domenica Lorusso, MD, PhD